BRCA1-mediated signaling pathways in ovarian carcinogenesis (Q39480429)

12 September 2017

title

BRCA1-mediated signaling pathways in ovarian carcinogenesis (English)

1 reference

12 September 2017

1 reference

Tejaswita M Karve

1

1 reference

12 September 2017

Xin Li

series ordinal

2

1 reference

12 September 2017

Tapas Saha

series ordinal

3

1 reference

12 September 2017

publication date

2 September 2011

1 reference

Functional and Integrative Genomics

12 September 2017

published in

1 reference

12 September 2017

volume

12

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

63-79

1 reference

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Analysis of the expression of human tumor antigens in ovarian cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

BRCA1 regulates gene expression for orderly mitotic progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Making the best of PARP inhibitors in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Ovarian cancer: epidemiology, biology, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Dual-specificity MAP kinase phosphatases (MKPs) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

FOXP1: a potential therapeutic target in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

BMP-2 signaling in ovarian cancer and its association with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Targeted therapy for cancer using PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Cyclin D1 gene (CCND1) mutations in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

The oncogenic activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

BRCA1 regulation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

The role of ephrins and Eph receptors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Seven new members of the Sox gene family expressed during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10142-011-0251-2

Frequency of BRCA1 dysfunction in ovarian cancer

21 January 2018

1 reference

12 December 2020

Transcriptional regulation of the base excision repair pathway by BRCA1

1 reference

12 December 2020

Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones

1 reference

12 December 2020

Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer

1 reference

12 December 2020

Claudins as diagnostic and prognostic markers in gynecological cancer

1 reference

12 December 2020

The diagnostic role of claudins in serous effusions

1 reference

12 December 2020

HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma

1 reference

12 December 2020

G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery

1 reference

12 December 2020

Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

1 reference

12 December 2020

Clinical significance of serum Dkk-3 in patients with gynecological cancer

1 reference

12 December 2020

Conserved POU/OCT- and GATA-binding sites in 5'-flanking promoter region of mammalian WNT8B orthologs.

1 reference

12 December 2020

Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis

1 reference

12 December 2020

New potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studies

1 reference

12 December 2020

Clinical significance of serum DKK-1 in patients with gynecological cancer

1 reference

12 December 2020

Involvement of OSP/claudin-11 in oligodendrocyte membrane interactions: role in biology and disease

1 reference

12 December 2020

Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation

1 reference

12 December 2020

Mutation analysis of the Smad6 and Smad7 gene in human ovarian cancers

1 reference

12 December 2020

10.1007/S10142-011-0251-2

Identifiers

DOI

1 reference

12 September 2017

1 reference